Literature DB >> 20943021

Detection of antibodies against Babesia bovis and Babesia bigemina in calves from the region of Araguaína, State of Tocantins, Brazil.

Hébelys Ibiapina da Trindade1, Gleisom Ribeiro de Araújo Silva, Márcia Cristina Alves Teixeira, Marlos Gonçalves Sousa, Rosângela Zacarias Machado, Fagner Luiz da Costa Freitas, Katyane de Sousa Almeida.   

Abstract

The aim of this study was to determine the seroprevalence of antibodies against B. bovis and B. bigemina in calves from the region of Araguaína, State of Tocantins, Brazil. In this research we used sera obtained from 506 calves, from both genders and of 8 to 24 months old, to detect antibodies by indirect Enzyme-Linked Immunosorbent Assay (ELISA-test). Statistical analysis of the data was performed using the Chi-square (χ²) test with Yates correction. The seroprevalence obtained was 90.5 and 91.7% for B. bigemina and B. bovis, respectively, characterizing the region as an area of enzootic stability for the species analyzed. The seroprevalence to B. bovis showed higher positivity among calves 19-24 months old.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943021     DOI: 10.1590/s1984-29612010000300008

Source DB:  PubMed          Journal:  Rev Bras Parasitol Vet        ISSN: 0103-846X


  2 in total

1.  High co-infection rates of Babesia bovis, Babesia bigemina, and Anaplasma marginale in water buffalo in Western Cuba.

Authors:  Dasiel Obregón; Alejandro Cabezas-Cruz; Yasmani Armas; Jenevaldo B Silva; Adivaldo H Fonseca; Marcos R André; Pastor Alfonso; Márcia C S Oliveira; Rosangela Z Machado; Belkis Corona-González
Journal:  Parasitol Res       Date:  2019-01-28       Impact factor: 2.289

2.  Genetic diversity of Babesia bovis in beef cattle in a large wetland in Brazil.

Authors:  Natalia Serra Mendes; Inalda Angélica de Souza Ramos; Heitor Miraglia Herrera; João Bosco Vilela Campos; João Victor de Almeida Alves; Gabriel Carvalho de Macedo; Rosangela Zacarias Machado; Marcos Rogério André
Journal:  Parasitol Res       Date:  2019-05-11       Impact factor: 2.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.